NRIX
NRIX
US67080M1036
Nurix Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 31.05.2026
Q1 '26 28.02.2026
Market & Enterprise Value
Market Cap
2.32B EUR
1.84B EUR
1.65B EUR
Enterprise Value
1.92B EUR
1.83B EUR
1.64B EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
-20.98x
--
--
Price to Sales
63.09x
50.09x
23.01x
Price to Book
5.76x
4.57x
3.43x
EV/Revenue
52.21x
49.83x
22.83x
EV/EBITDA
-5.44x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-7.1%
-16.53%
-16.46%
ende